Lymphedema after pelvic and para-aortic lymphadenectomy-results of a systematic evaluation in patients with cervical and endometrial carcinoma

被引:10
作者
Armbrust, R. [1 ,2 ]
Auletta, V [1 ,2 ]
Cichon, G. [1 ,2 ]
Vercellino, G. [1 ,2 ,3 ]
Yost, K. [2 ,3 ]
Sehouli, J. [1 ,2 ]
机构
[1] Charite, Dept Gynecol, Ctr Oncol Surg, Augustenburger Pl 1, D-13353 Berlin, Germany
[2] Helios Klinikum Niederberg, Dept Gynecol, Velbert, Germany
[3] Mayo Clin, Div Epidemiol, Dept Hlth Sci Res, Rochester, MN USA
关键词
Lymphedema; Lymphadenectomy; Endometrial cancer; Cervical cancer; LOWER-EXTREMITY LYMPHEDEMA; PREVALENCE; CANCER;
D O I
10.1007/s00404-022-06779-8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background Lymphedema is a frequent complication after surgical treatment in gynecological oncology with substantial impact on patients ' Quality of Life (QoL). Little is known about screening instruments and prevention. Primary objective was to develop and validate the German version of a 13 items screening questionnaire (SQ) developed by Yost et al. to provide a valid instrument for early diagnosis of lower extremity lymphedema (LEL). Methods After translation the SQ was used in pt. with cervical or endometrial cancer who underwent pelvic/paraaortic Lymphadenectomy. Sensitivity and specifity were analysed regarding possible prediction and influencing factors of LEL. Results 67 pt. had LEL (N = 128). Nearly 50% of women in each group (38 in LEL + e 30 in LEL - ) had a body mass index (BMI) > 30 kg/m(2). Number of removed lymphnodes, radiotherapy and were significantly associated with development of LEL. Translated Mayo Clinic questionnaire can be used with reliable specifity and sensitivity. Four additional questions improved the diagnostic accuracy of the SQ. Conclusions The translated SQ is a valuable and predictive tool for screening and early detection of LEL in Gynecological cancer surgery and can even improved by adding simple questions.
引用
收藏
页码:1557 / 1565
页数:9
相关论文
共 15 条
[1]   Lymphedema after gynecological cancer treatment - Prevalence, correlates, and supportive care needs [J].
Beesley, Vanessa ;
Janda, Monika ;
Eakin, Elizabeth ;
Obermair, Andreas ;
Battistutta, Diana .
CANCER, 2007, 109 (12) :2607-2614
[2]  
Boris M, 1997, Oncology (Williston Park), V11, P99
[3]   The grading of lymphedema in oncology clinical trials [J].
Cheville, AL ;
McGarvey, CL ;
Petrek, JA ;
Russo, SA ;
Thiadens, SRJ ;
Taylor, ME .
SEMINARS IN RADIATION ONCOLOGY, 2003, 13 (03) :214-225
[4]   Lymphedema Beyond Breast Cancer [J].
Cormier, Janice N. ;
Askew, Robert L. ;
Mungovan, Kristi S. ;
Xing, Yan ;
Ross, Merrick I. ;
Armer, Jane M. .
CANCER, 2010, 116 (22) :5138-5149
[5]  
F?ldi M., 2003, TXB LYMPOHOLOGY
[6]  
Finnane A, 2011, EXPERT REV PHARM OUT, V11, P287, DOI [10.1586/erp.11.30, 10.1586/ERP.11.30]
[7]   Lymphedema following gynecological cancer: Results from a prospective, longitudinal cohort study on prevalence, incidence and risk factors [J].
Hayes, Sandra C. ;
Janda, Monika ;
Ward, Leigh C. ;
Reul-Hirche, Hildegard ;
Steele, Megan L. ;
Carter, Johnathan ;
Quinn, Michael ;
Cornish, Bruce ;
Obermair, Andreas .
GYNECOLOGIC ONCOLOGY, 2017, 146 (03) :623-629
[8]   The risk of lymphedema after postoperative radiation therapy in endometrial cancer [J].
Mitra, Devarati ;
Catalano, Paul J. ;
Cimbak, Nicole ;
Damato, Antonio L. ;
Muto, Michael G. ;
Viswanathan, Akita N. .
JOURNAL OF GYNECOLOGIC ONCOLOGY, 2016, 27 (01)
[9]   Lymphoedema: an underestimated health problem [J].
Moffatt, CJ ;
Franks, PJ ;
Doherty, DC ;
Williams, AF ;
Badger, C ;
Jeffs, E ;
Bosanquet, N ;
Mortimer, PS .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2003, 96 (10) :731-738
[10]  
Neuhuttler E, 2003, BEITRAG EPIDEMIOLOGI